Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients

Table 3 Stepwise multivariate proportional hazards model for predictors of overall survival

Variable		Hazard ratio (95%CI)	P value
mGPS			0.017
	0 vs 1	1.135 (0.717-1.797)	0.588
	0 vs 2	3.212 (1.437-7.716)	0.004
LMR	> 3.4 vs ≤ 3.4	1.658 (1.092-2.518)	0.018
CA19-9 (U/mL)	≤ 27 vs > 27	1.482 (1.007-2.182)	0.046
AST (IU/L)	< 40 vs≥ 40	2.377 (1.359-4.155)	0.002
KM treatment duration (mo)	≥ 2.9 vs < 2.9	1.718 (1.160-2.543)	0.007

mGPS: Modified Glasgow prognostic score; LMR: Lymphocyte to monocyte ratio; CA19-9: Carbohydrate antigen 19-9; AST: Aspartate aminotransferase; KM: Korean Medicine.